← All indications
Hypertriglyceridemia
A condition of elevated levels of TRIGLYCERIDES in the blood.
Subtype terms (3)
More specific conditions that are subtypes of Hypertriglyceridemia in the MeSH hierarchy.
- Hyperlipoproteinemia Type IV
7 drugs (4 approved, 3 experimental)
- Hyperlipoproteinemia Type V
4 drugs (1 approved, 3 experimental)
- Hypertriglyceridemic Waist
1 drug approved
Drugs by status
Approved for this indication (7)
Phase 4 trials (16)
Phase 3 trials (18)
Phase 2 trials (24)
Phase 1 trials (15)
Other trials (35)
- maltodextrin
- sucrose
- bezafibrate
- canola oil
- dark chocolate
- egg
- linseed oil
- tenofovir
- hydroxytyrosol
- nevulose
- soybean oil
- whey protein
- cow milk
- phytosterol
- lactose
- safflower oil
- setmelanotide
- sunflower oil
- alpha-lactalbumin
- flax
- palmitic acid
- aronia juice
- amino acids
- pioglitazone
- avocado
- phospholipids
- high oleic safflower
- guar gum
- tea
- water
- +5 more
Organizations
Organization Involved with Phase 4 Indications (48)
- Baxalta
- GlaxoSmithKline
- Kuhnil Pharmaceutical Co., Ltd.
- Solvay
- National Center for Complementary and Integrative Health (NCCIH)
- National Heart, Lung, and Blood Institute (NHLBI)
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- United States Army
- Felizarta, Franco, M.D.
- Hebei University
- Birjand University of Medical Sciences
- Harvard University
- Eastern Virginia Medical School
- Gachon University
- Georgetown University
- Guangdong Provincial Hospital of Traditional Chinese Medicine
- Inje University
- Jinhua Central Hospital
- Johns Hopkins University
- Kunming Medical University
- Nanjing Medical University
- Oregon Health and Science University
- Rio de Janeiro State University
- Sanford Health
- Tufts University
- Yonsei University
- Wenzhou Medical University
- University of Cincinnati
- University of Utah
- Federal University of Rio de Janeiro
- +18 more
Organization Involved with Phase 3 Indications (59)
- Acasti Pharma Inc.
- Takeda
- Sumitomo
- Kowa
- Merck
- Pfizer
- Bayer
- Essentialis, Inc.
- Excelsior Medical
- Hengrui Therapeutics, Inc.
- Institut Pasteur
- Ionis Pharmaceuticals, Inc.
- Mochida Pharmaceutical Company, Ltd.
- Micelle BioPharma
- Trygg Pharma, Inc.
- Valbiotis
- Rottapharm
- Brown University
- Chiba University
- Harbin Medical University
- Thomas Jefferson University
- University of Melbourne
- University of Rochester
- University of Toronto
- University of Valencia
- University of Virginia
- Mayo Clinic
- University of British Columbia
- University of Cologne
- UFR des Sciences Pharmaceutiques et Biologiques, Nantes, France
- +29 more
Organization Involved with Phase 2 Indications (39)
- Regeneron
- Kadmon
- MediciNova
- Novartis
- Arisaph Pharmaceuticals Inc
- Cortria Corporation
- Esperion Therapeutics
- Gemphire Therapeutics, Inc.
- Matinas Biopharma, Inc
- Medical Research Laboratories International
- Afimmune
- National Institute of Allergy and Infectious Diseases (NIAID)
- Bastyr University
- Radiant Research
- Sanford Research
- University of Michigan
- Uppsala University
- Meridien Research
- PMG Research
- Jacksonville Center for Clinical Research
- Sterling Research Group, Ltd
- Catabasis
- Cadila Healthcare
- TriCities Medical Research
- Pharma Medica
- Midwest Institute for Clinical Research
- Frederick C. Smith Clinic
- Allied Research International
- L-Marc Research Center
- University of Colorado
- +9 more
Organization Involved with Phase 1 Indications (19)
- Arrowhead Pharmaceuticals
- NuBiyota
- Thetis Pharmaceuticals LLC
- National Institutes of Health (NIH)
- University of Pennsylvania
- Rockefeller University
- Dong-A University
- The Rogosin Institute
- University of Bern
- Celerion
- BioPharma Services
- Scripps
- Cantonal Hospital of St. Gallen
- PRACS
- Washington University in St. Louis
- NorthSea Therapeutics B.V.
- DongKoo Bio & Pharma
- Staten Biotechnology BV
- Inquis Clinical Research
Organization Involved with Other Experimental Indications (45)
- Bristol-Myers Squibb
- Arctic Nutrition AS
- DSM
- Provident Clinical Research
- Rhythm Pharmaceuticals, Inc.
- Fundação de Amparo à Pesquisa do Estado de São Paulo
- National Center for Research Resources (NCRR)
- National Institute on Aging (NIA)
- United States Department of Agriculture
- University of Illinois
- University of Arizona
- Allegiance Health
- Baylor University
- China Academy of Chinese Medical Sciences
- Hiroshima University
- Hoosier Cancer Research Network
- Legacy Health System
- Lund University
- Maine Center for Lipids and Cardiovascular Health
- Los Angeles Biomedical Research Institute
- New York University
- Stanford University
- University of Bari
- Wake Forest University
- Fudan University
- Laval University
- University of California, Los Angeles
- University of Naples Frederico II
- Clinical Research Institute HUCH Ltd
- Government of Mexico
- +15 more